#USA #LabConnect #Johnson City #Global Services #Bill Finger

LabConnect Welcomes Bill Finger as Senior Vice President of Global Strategic Services

LabConnect, a pioneer in orchestrating Central Laboratory Services and consulting across the globe, recently announced the appointment of Bill Finger as their Senior Vice President of Global Strategic Services, effective September 10, 2025. This strategic move aims to bolster LabConnect's capabilities in providing innovative solutions and services in the diagnostics and clinical research sector.

Bill brings with him over 25 years of rich experience in diagnostics and clinical research, showcasing an impressive portfolio within the pharmacy and laboratory landscape. His previous roles include Vice President and General Manager of Pharma Services at Quest Diagnostics, where he led initiatives to enhance service offerings and operational efficiency. Prior to Quest Diagnostics, he was Chief Operating Officer at Interpace Pharma Solutions, and held varied leadership positions in scientific affairs at LabCorp and other esteemed organizations.

In his new role at LabConnect, Bill will helm the Scientific Services, Consulting Services, Data Management, and Functional Service Provider (FSP) teams, a move aimed at streamlining LabConnect's service provision while enhancing client satisfaction. Wes Wheeler, the CEO of LabConnect, expressed enthusiasm regarding the appointment, stating, "Bill's leadership in diagnostic and clinical research is a tremendous asset to LabConnect. His extensive experience will ensure we continue to meet client demands proactively and deliver cutting-edge solutions."

Bill's innovative approach and proven track record are expected to significantly foster LabConnect's commitment to operational excellence. As the healthcare landscape continues to evolve, having a visionary leader like Bill Finger will undoubtedly enhance LabConnect's strategic positioning in this competitive environment.

LabConnect has established itself as the go-to provider for Central Laboratory Services, offering specialized services for complex studies, including immuno-oncology, and therapies related to cell and gene sciences. The integration of cutting-edge technologies and the expertise available within LabConnect empowers drug development companies to focus on their core objectives while relying on one provider for all their central laboratory service needs.

Launched with the vision to simplify the complexities involved in clinical studies, LabConnect combines state-of-the-art technology, unparalleled laboratory access, and specialized testing capabilities. With Bill's appointment, LabConnect is poised to further its mission of delivering world-class services that accommodate the unique needs of its clients across major and emerging markets.

For additional information and updates about LabConnect and its services, please visit their official website www.LabConnect.com or follow their corporate updates on LinkedIn. With the leadership of Bill Finger steering their global strategic services, LabConnect is set to redefine standards in diagnostics and consulting, ensuring that clients receive exceptional service delivery tailored to their unique requirements.